Samsung Biologics Launches ExellenS™ Framework

Samsung Biologics, South Korea’s leading CDMO, has introduced ExellenS™, an optimized manufacturing framework aimed at streamlining and elevating biomanufacturing performance across its network. The initiative builds on the company’s proven strengths in plant design, digitalization, and operational excellence.

Standardization for Precision and Speed

ExellenS™ unifies equipment, processes, and functional standards across all Samsung Biologics facilities. This consistent framework ensures identical precision and reliability, enabling faster technology transfers, smoother regulatory approvals, and scalable production to meet global demand efficiently.

Driving Global Biomanufacturing Excellence

By implementing ExellenS™, Samsung Biologics reinforces its leadership in global biologics manufacturing. The framework delivers high-quality, predictable outcomes while empowering clients to accelerate time-to-market for vital therapies, underscoring the company’s commitment to innovation and operational excellence.